Outcome | No. of studies | No.of patients | Results | OR (95% CI) | P value | HG p value | ||
---|---|---|---|---|---|---|---|---|
TACE (+) | TACE (−) | TACE (+) | TACE (−) | |||||
RCTs | Â | Â | Â | Â | Â | Â | Â | Â |
5-years disease-free survival | 167 | 172 | 29.3% | 31.9% | 0.85 (0.53, 1.39) | 0.52 | 0.16 | |
5-years overall survival | 167 | 172 | 36.5% | 38.3% | 0.89 (0.56, 1.41) | 0.61 | 0.11 | |
Total recurrence | 116 | 124 | 74.1% | 74.2% | 1.03 (0.36, 2.90) | 0.96 | 0.07 | |
Intrahepatic recurrence | 116 | 124 | 50.0% | 46.7% | 1.32 (0.47, 3.70) | 0.59 | 0.02 | |
Extrahepatic recurrence | 116 | 124 | 28.4% | 22.5% | 1.37 (0.42, 4.43) | 0.60 | 0.04 | |
Overall morbidity | 113 | 127 | 20.3% | 21.2% | 0.97 (0.52, 1.82) | 0.93 | 0.14 | |
Mortality | 163 | 174 | 3.1% | 4.0% | 0.70 (0.22, 2.30) | 0.56 | 0.95 | |
NRCTs | Â | Â | Â | Â | Â | Â | Â | Â |
5-years disease-free survival | 1108 | 1395 | 32.4% | 29.8% | 1.28 (0.98, 1.67) | 0.07 | 0.04 | |
5-years overall survival | 871 | 1291 | 40.9% | 46.1% | 0.86 (0.55, 1.32) | 0.48 | <0.01 | |
Total recurrence | 559 | 795 | 58.1% | 55.8% | 0.98 (0.77, 1.25) | 0.86 | 0.11 | |
Intrahepatic recurrence | 546 | 675 | 51.2% | 56.5% | 0.79 (0.62, 1.01) | 0.06 | 0.84 | |
Extrahepatic recurrence | 403 | 467 | 8.4% | 7.0% | 1.22 (0.73, 2.06) | 0.44 | 0.74 | |
Overall morbidity | 470 | 676 | 31.0% | 27.9% | 1.03 (0.79, 1.36) | 0.81 | 0.50 | |
Mortality | 937 | 1151 | 4.3% | 2.9% | 1.39 (0.85, 2.28) | 0.19 | 0.74 | |
Studies with complete matched clinicopathological parameters | Â | Â | Â | Â | Â | Â | Â | Â |
5-years disease-free survival | 421 | 404 | 26.8% | 22.0% | 1.13 (0.62, 2.05) | 0.69 | 0.02 | |
5-years overall survival | 452 | 511 | 44.6% | 35.2% | 1.15 (0.76, 1.74) | 0.50 | 0.08 | |
Total recurrence | 297 | 349 | 73.7% | 76.5% | 0.91 (0.62, 1.33) | 0.64 | 0.15 | |
Intrahepatic recurrence | 328 | 456 | 56.4% | 60.1% | 0.81 (0.59, 1.11) | 0.20 | 0.69 | |
Extrahepatic recurrence | 297 | 349 | 13.1% | 9.4% | 1.40 (0.83, 2.38) | 0.21 | 0.80 | |
Overall morbidity | 191 | 344 | 36.1% | 28.2% | 1.36 (0.91, 2.01) | 0.13 | 0.48 | |
Mortality | 339 | 423 | 4.4% | 3.7% | 1.16 (0.52, 2.57) | 0.71 | 0.50 |